21.4% sero-prevalence among Indian population of over 18 years: ICMR

The survey was conducted from December 17, 2020 to January 8, 2021

Coronavirus testing
Coronavirus testing | File photo
ANI General News
2 min read Last Updated : Feb 04 2021 | 6:45 PM IST

The sero-prevalence in the population above the age of 18 years was 21.4 per cent in the third sero-survey conducted from December 17, 2020 to January 8, 2021, said the Indian Council of Medical Research (ICMR) on Thursday.

During a press conference, Balram Bhargava, DG ICMR said that a total of 7,171 healthcare workers were included among the 28,589 individuals in the third sero-survey.

"The third sero-survey was done from December 17, 2020, to January 8, 2021. A general population of 28,589 individuals were included and another group of 7,171 healthcare workers were also included... Above the age of 18 years the sero-prevalance was 21.4 per cent. Sero-prevalence among children aged 10-17 years was 25.3 per cent," Bhargava said.

"Amongst healthcare workers, sero-prevalence was highest overall with 25.7 per cent. Statistically, it was not different between doctors, nurses, field staff, and paramedics, but it was highest among doctors and nurses with 26.6 per cent as against the administrative staff which was 24.9 per cent. IgG antibody against S1 Receptor Binding Domain was detected," he added.

The sero-prevalence means the presence of antibodies against COVID-19 in the population.

He said that the survey was conducted in the same 700 villages/wards.

"A total of 70 districts from 21 States selected during the 1st and 2nd rounds. 100 Healthcare Workers (HCWs) per district, working in Taluk hospitals/CHCs/PHCs (all HCWs from selected health facilities)," he said.

According to the survey, a large proportion still remains vulnerable hence prevention is the key and vaccines are necessary, Bhargava said.

The overall findings of the survey are as follows:--

According to the Indian Council of Medical Research (ICMR), sero-surveys help to understand the proportion of the population exposed to SARS-CoV-2 infection including asymptomatic individuals. Depending upon the level of sero-prevalence of infection, appropriate public health interventions can be planned and implemented for prevention and control of the disease.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusICMRCoronavirus Vaccine

First Published: Feb 04 2021 | 5:20 PM IST

Next Story